{
    "2019-03-13": [
        [
            {
                "time": "2019-03-13",
                "original_text": "Pfizer (PFE) Gains But Lags Market: What You Should Know",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Gains",
                        "Lags Market"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-13",
                "original_text": "After Hours Most Active for Mar 13, 2019: MSFT, LLY, F, CMCSA, PFE, FOX, CTL, HPQ, PCG, AMD, AAPL, ENDP",
                "features": {
                    "keywords": [
                        "Most Active",
                        "PFE"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "healthcare",
                        "automotive",
                        "media",
                        "telecommunications"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-13",
                "original_text": "Aerie (AERI) Receives FDA Nod for Rocklatan to Treat Glaucoma",
                "features": {
                    "keywords": [
                        "FDA Nod",
                        "Rocklatan",
                        "Glaucoma"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-03-13",
                "original_text": "Lilly's Cyramza Successful in Phase III First-Line NSCLC Study",
                "features": {
                    "keywords": [
                        "Cyramza",
                        "Phase III",
                        "NSCLC"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-03-13",
                "original_text": "Theravance (TBPH) Starts Dosing in Ulcerative Colitis Study",
                "features": {
                    "keywords": [
                        "Dosing",
                        "Ulcerative Colitis"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-03-13",
                "original_text": "Dow Analyst Moves: PFE",
                "features": {
                    "keywords": [
                        "Analyst Moves",
                        "PFE"
                    ],
                    "sentiment_score": 0.55,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-13",
                "original_text": "Health Care Sector Update for 03/13/2019: NVCN, CASI, LXRX, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health Care Sector",
                        "Update"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-13",
                "original_text": "Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for March 14, 2019",
                "features": {
                    "keywords": [
                        "Ex-Dividend Date",
                        "Scheduled"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-13",
                "original_text": "FDA medical adviser: 'Congress is owned by pharma'",
                "features": {
                    "keywords": [
                        "FDA",
                        "Congress",
                        "pharma"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "government",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}